Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Cipla
Johnson and Johnson
McKinsey
Deloitte
Covington
Colorcon
McKesson

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022198

« Back to Dashboard

NDA 022198 describes SANCUSO, which is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the SANCUSO profile page.

The generic ingredient in SANCUSO is granisetron. There are twenty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the granisetron profile page.
Summary for 022198
Tradename:SANCUSO
Applicant:Kyowa Kirin
Ingredient:granisetron
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 022198
Medical Subject Heading (MeSH) Categories for 022198
Suppliers and Packaging for NDA: 022198
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SANCUSO granisetron FILM, EXTENDED RELEASE;TRANSDERMAL 022198 NDA Kyowa Kirin, Inc. 42747-726 N 42747-726-01
SANCUSO granisetron FILM, EXTENDED RELEASE;TRANSDERMAL 022198 NDA Physicians Total Care, Inc. 54868-5985 E 54868-5985-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength3.1MG/24HR
Approval Date:Sep 12, 2008TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jan 22, 2025Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
QuintilesIMS
Healthtrust
Fish and Richardson
AstraZeneca
Dow
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.